Hualan Biological EngineeringInc (002007) — Cash Flow Reinvestment Rate
Hualan Biological EngineeringInc (002007) has a Cash Flow Reinvestment Rate of 0.11x as of September 2025, reinvesting CN¥36.14 Million (capex CN¥36.14 Million ) from operating cash flow of CN¥319.46 Million. Check how high is Hualan Biological EngineeringInc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hualan Biological EngineeringInc Cash Flow Reinvestment Rate (2003–2024)
Historical reinvestment intensity for Hualan Biological EngineeringInc across 22 annual periods. Explore Hualan Biological EngineeringInc strategic investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Hualan Biological EngineeringInc (2003–2024)
Year-by-year capital reinvestment analysis for Hualan Biological EngineeringInc. For live market cap and broader valuation context, see 002007 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.57x | CN¥599.21 Million | CN¥1.06 Billion | CN¥255.79 Million | ▼ -56.5% |
| 2023 | 1.30x | CN¥1.75 Billion | CN¥1.35 Billion | CN¥753.41 Million | ▼ -51.5% |
| 2022 | 2.68x | CN¥2.57 Billion | CN¥957.31 Million | CN¥393.95 Million | ▲ +103.8% |
| 2021 | 1.32x | CN¥1.89 Billion | CN¥1.43 Billion | CN¥811.35 Million | ▲ +106.5% |
| 2020 | 0.64x | CN¥845.31 Million | CN¥1.33 Billion | CN¥621.44 Million | ▲ +2.9% |
| 2019 | 0.62x | CN¥845.09 Million | CN¥1.36 Billion | CN¥272.95 Million | ▼ -14.4% |
| 2018 | 0.72x | CN¥936.97 Million | CN¥1.29 Billion | CN¥183.26 Million | ▲ +3.6% |
| 2017 | 0.70x | CN¥124.12 Million | CN¥177.42 Million | CN¥108.54 Million | ▼ -3.8% |
| 2016 | 0.73x | CN¥239.94 Million | CN¥329.94 Million | CN¥220.66 Million | ▼ -29.9% |
| 2015 | 1.04x | CN¥569.20 Million | CN¥548.62 Million | CN¥229.34 Million | ▲ +270.5% |
| 2014 | 0.28x | CN¥139.21 Million | CN¥497.15 Million | CN¥139.21 Million | ▼ -42.6% |
| 2013 | 0.49x | CN¥249.21 Million | CN¥510.70 Million | CN¥249.21 Million | ▲ +64.0% |
| 2012 | 0.30x | CN¥147.15 Million | CN¥494.69 Million | CN¥147.15 Million | ▼ -30.4% |
| 2011 | 0.43x | CN¥143.59 Million | CN¥335.93 Million | CN¥143.59 Million | ▲ +74.1% |
| 2010 | 0.25x | CN¥149.67 Million | CN¥609.53 Million | CN¥149.67 Million | ▼ -8.1% |
| 2009 | 0.27x | CN¥162.43 Million | CN¥607.73 Million | CN¥162.43 Million | ▼ -66.1% |
| 2008 | 0.79x | CN¥126.90 Million | CN¥161.18 Million | CN¥126.90 Million | ▼ -34.1% |
| 2007 | 1.19x | CN¥213.92 Million | CN¥179.02 Million | CN¥213.92 Million | ▼ -27.7% |
| 2006 | 1.65x | CN¥217.30 Million | CN¥131.43 Million | CN¥217.30 Million | ▲ +177.2% |
| 2005 | 0.60x | CN¥58.59 Million | CN¥98.24 Million | CN¥58.59 Million | ▼ -41.8% |
| 2004 | 1.02x | CN¥22.00 Million | CN¥21.48 Million | CN¥22.00 Million | ▼ -89.6% |
| 2003 | 9.81x | CN¥32.82 Million | CN¥3.35 Million | CN¥32.82 Million | — |